These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 11266415

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics and inflammatory fluid penetration of sparfloxacin.
    Johnson JH, Cooper MA, Andrews JM, Wise R.
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2444-6. PubMed ID: 1336947
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin.
    Child J, Andrews JM, Wise R.
    Antimicrob Agents Chemother; 1995 Feb; 39(2):513-5. PubMed ID: 7726523
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration.
    Wise R, Andrews JM, Marshall G, Hartman G.
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1508-10. PubMed ID: 10348784
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and tissue penetration of orally administered pefloxacin.
    Webberley JM, Andrews JM, Ashby JP, McLeod A, Wise R.
    Eur J Clin Microbiol; 1987 Oct; 6(5):521-4. PubMed ID: 3481335
    [Abstract] [Full Text] [Related]

  • 32. The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
    Cooper MA, Nye K, Andrews JM, Wise R.
    J Antimicrob Chemother; 1990 Oct; 26(4):533-8. PubMed ID: 2174853
    [Abstract] [Full Text] [Related]

  • 33. Oral bioavailability of trovafloxacin with and without food in healthy volunteers.
    Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
    Stone JW, Andrews JM, Ashby JP, Griggs D, Wise R.
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
    [Abstract] [Full Text] [Related]

  • 36. Single-dose pharmacokinetics and penetration of BMS 284756 into an inflammatory exudate.
    Wise R, Gee T, Marshall G, Andrews JM.
    Antimicrob Agents Chemother; 2002 Jan; 46(1):242-4. PubMed ID: 11751144
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.
    Andrews JM, Honeybourne D, Brenwald NP, Bannerjee D, Iredale M, Cunningham B, Wise R.
    J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050
    [Abstract] [Full Text] [Related]

  • 39. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A.
    Ann Acad Med Stetin; 2002 Jun; 48():59-73. PubMed ID: 14601469
    [Abstract] [Full Text] [Related]

  • 40. Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid.
    Landersdorfer CB, Kirkpatrick CM, Kinzig M, Bulitta JB, Holzgrabe U, Drusano GL, Sörgel F.
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3902-7. PubMed ID: 19564368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.